Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

532 ARTÍCULOS , VIENDO DEL 1 AL 15

Tacrine-Natural-Product Hybrids for Alzheimer's Disease Therapy

Oset-Gasque MJ, Marco-Contelles JL.

Curr Med Chem. 2020;27(26):4392-4400. doi: 10.2174/0929867325666180403151725.

Primary Endpoints in Current Phase II/III Trials for Alzheimer Disease: A Systematic Survey of Trials Registered at ClinicalTrials.gov

Takeshima N, Ishiwata K, Sozu T, Furukawa TA.

Alzheimer Dis Assoc Disord. 2020 Jan-Mar;34(1):97-100. doi: 10.1097/WAD.0000000000000297.

Time for Well-Powered Controlled Prospective Studies to Test a Causal Role for Herpes Viruses in Alzheimer's Disease Using Antiherpetic Drugs

Goldschmidt-Clermont PJ, Volinsky FG, LaRosa SP, Gilbert JR, Periçak-Vance MA.

J Gerontol A Biol Sci Med Sci. 2020 May 22;75(6):1058-1060. doi: 10.1093/gerona/glz150.

Natural Products as Potential Anti-Alzheimer Agents

Panda SS, Jhanji N.

Curr Med Chem. 2020;27(35):5887-5917. doi: 10.2174/0929867326666190618113613.

Multifunctional Ligands Targeting Phosphodiesterase as the Future Strategy for the Symptomatic and Disease-Modifying Treatment of Alzheimer's Disease

Jankowska A, Wesołowska A, Pawłowski M, Chłoń-Rzepa G.

Curr Med Chem. 2020;27(32):5351-5373. doi: 10.2174/0929867326666190620095623.

Zinc-mediated Neurotransmission in Alzheimer's Disease: A Potential Role of the GPR39 in Dementia

Rychlik M, Mlyniec K.

Curr Neuropharmacol. 2020;18(1):2-13. doi: 10.2174/1570159X17666190704153807.

Amyloid Beta Hypothesis in Alzheimer's Disease: Major Culprits and Recent Therapeutic Strategies

Vijayan D, Chandra R.

Curr Drug Targets. 2020;21(2):148-166. doi: 10.2174/1389450120666190806153206.

AMPK: Potential Therapeutic Target for Alzheimer's Disease

Yang L, Jiang Y, Shi L, Zhong D, Li Y, Li J, Jin R.

Curr Protein Pept Sci. 2020;21(1):66-77. doi: 10.2174/1389203720666190819142746.

Neuroprotective effects of resveratrol in Alzheimer's disease

Rao YL, Ganaraja B, Joy T, Pai MM, Ullal SD, Murlimanju BV.

Front Biosci (Elite Ed). 2020 Jan 1;12(1):139-149. doi: 10.2741/E863.

Insights from Drosophila melanogaster model of Alzheimer's disease

Tue NT, Dat TQ, Ly LL, Anh VD, Yoshida H.

Front Biosci (Landmark Ed). 2020 Jan 1;25(1):134-146. doi: 10.2741/4798.

Diabetic Theory in Anti-Alzheimer's Drug Research and Development - Part 1: Therapeutic Potential of Antidiabetic Agents

Jankowska A, Wesołowska A, Pawłowski M, Chłoń-Rzepa G.

Curr Med Chem. 2020;27(39):6658-6681. doi: 10.2174/0929867326666191011144818.

Navigating Alzheimer's Disease via Chronic Stress: The Role of Glucocorticoids

Sharma VK, Singh TG.

Curr Drug Targets. 2020;21(5):433-444. doi: 10.2174/1389450120666191017114735.

Inhibitors of Cholinesterases in Pharmacology: the Current Trends

Pohanka M.

Mini Rev Med Chem. 2020;20(15):1532-1542. doi: 10.2174/1389557519666191018170908.

An Increasing Role of Polyphenols as Novel Therapeutics for Alzheimer's: A Review

Karim N, Khan H, Khan I, Guo O, Sobarzo-Sánchez E, Rastrelli L, Kamal MA.

Med Chem. 2020;16(8):1007-1021. doi: 10.2174/1573406415666191105154407.

The path forward in Alzheimer's disease therapeutics: Reevaluating the amyloid cascade hypothesis

Tolar M, Abushakra S, Sabbagh M.

Alzheimers Dement. 2020 Nov;16(11):1553-1560. doi: 10.1016/j.jalz.2019.09.075. Epub 2020 Jan 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias